Skip to main content
. 2018 May 22;29(8):2169–2177. doi: 10.1681/ASN.2017121273

Table 3.

Estimated survival for patients who initiate dialysis compared with patients who receive medical management, by age group and eGFR

Age, yr eGFR (ml/min per 1.73 m2) Median Survival in Months (25th, 75th percentile) Difference in Median Survival (mo)
Dialysis Medical Management
60 <6 71 (28, NE) 17 (5, 39) 54
6–<9 67 (26, NE) 45 (16, 90) 22
9–<12 54 (20, NE) 52 (19, NE) 2
65 <6 37 (13, 75) 11 (3, 26) 26
6–<9 36 (12, 74) 30 (10, 64) 6
9–<12 42 (15, 85) 36 (12, 76) 6
75 <6 34 (11, 70) 9 (3, 22) 25
6–<9 29 (10, 62) 8 (2, 20) 21
9–<12 26 (9, 57) 21 (7, 46) 5
85 <6 24 (8, 52) 7 (2, 16) 17
6–<9 21 (7, 46) 6 (2, 15) 15
9–<12 21 (7, 47) 11 (3, 27) 10

NE values correspond to times which extend beyond the maximum follow-up time. eGFR values >12 ml/min per 1.73 m2 are not presented because they were not associated with higher dialysis survival in any age group.